Clin2
NCT06138821Possibly a fitRecruiting

Endoscopic sleeve gastroplasty for obesity and MASH

ObesityLiver DiseasesLiver FibrosisLiver FatMetabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated SteatohepatitisMASLDMASH

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests if a procedure called endoscopic sleeve gastroplasty helps people with obesity and a liver condition called MASH lose weight and improve their liver health. It might be an option if you have both obesity and MASH and haven't had weight-loss surgery before.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
132 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and have a BMI of 30 or more (or 27 with a weight-related health problem).
  • Your weight has been stable (not changed by more than 5%) for the past 6 months.
  • You are willing to avoid starting new weight-loss medications for 12 months and to follow diet counseling and regular check-ups.
  • You have not had prior bariatric surgery or endoscopic sleeve gastroplasty.
  • You do not have certain other liver diseases, severe acid reflux, or uncontrolled diabetes.
  • You do not drink heavily, smoke, or have certain other medical conditions (like bleeding problems or eating disorders).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06299644Not yet recruiting
Comparing two endoscopic sleeve gastroplasty techniques for weight loss

This study compares two similar minimally invasive procedures to help with weight loss. The goal is to see which technique is safer and more effective for people with a high body mass index (BMI).

Boston, Massachusetts
NCT06868992Recruiting
Study of MASH and cell changes in weight-loss surgery

This study looks at a possible link between MASH (liver inflammation with fat buildup) and tiny cell structures that help liver cells work. Researchers want to understand this better in people having weight-loss surgery, where a small liver sample will be taken.

Lyon, France
NCT07449520Not yet recruiting
Endoscopic sleeve gastroplasty for weight loss

This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.

Aix-en-Provence
NCT06657339Not yet recruiting
National registry for endoscopic sleeve gastrectomy for obesity

This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.

NCT07792226Recruiting
Stomach procedure for weight loss (ESG with fundal ablation)

This study tests a new procedure called endoscopic sleeve gastroplasty with fundal mucosal ablation to help with weight loss. It is an option for people with obesity who have not had success with other methods and who have not had prior stomach surgery.

Morgantown, West Virginia
NCT06420700Recruiting
Stomach Lining Ablation with Sleeve Gastroplasty for Weight Loss

This study combines two endoscopic procedures to help you lose weight: one that reduces the size of your stomach and one that alters the stomach lining. It is designed for people who are ready to commit to long-term diet changes.

Atlanta, Georgia

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.